Manipal Hospitals’ acquisition-led expansion is entering a key phase, with Jefferies initiating coverage with a Buy rating and Rs 870 target. The brokerage expects strong earnings growth, driven by the turnaround of Sahyadri Hospitals, new bed additions, higher utilisation and operating leverage. However, execution risks at Sahyadri and intensifying competition in Bengaluru remain key concerns for the investment case.
This story was originally reported by Economic Times — Markets. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
Crowd-sourced evaluation based on verified reader feedback
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.